[go: up one dir, main page]

WO1996031194A3 - Skin care compositions containing retinoids and liposomes - Google Patents

Skin care compositions containing retinoids and liposomes Download PDF

Info

Publication number
WO1996031194A3
WO1996031194A3 PCT/US1996/004557 US9604557W WO9631194A3 WO 1996031194 A3 WO1996031194 A3 WO 1996031194A3 US 9604557 W US9604557 W US 9604557W WO 9631194 A3 WO9631194 A3 WO 9631194A3
Authority
WO
WIPO (PCT)
Prior art keywords
skin care
liposomes
compositions containing
care compositions
containing retinoids
Prior art date
Application number
PCT/US1996/004557
Other languages
French (fr)
Other versions
WO1996031194A2 (en
WO1996031194A9 (en
Inventor
Jonas C T Wang
Mohammed Yusuf
Jue-Chen Liu
Original Assignee
Johnson & Johnson Consumer
Jonas C T Wang
Mohammed Yusuf
Liu Jue Chen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer, Jonas C T Wang, Mohammed Yusuf, Liu Jue Chen filed Critical Johnson & Johnson Consumer
Priority to EP96912539A priority Critical patent/EP0818988A2/en
Priority to EA199700289A priority patent/EA199700289A1/en
Priority to JP8530447A priority patent/JPH11503165A/en
Priority to APAP/P/1997/001101A priority patent/AP789A/en
Priority to NZ306694A priority patent/NZ306694A/en
Priority to AU55322/96A priority patent/AU5532296A/en
Priority to BR9604954A priority patent/BR9604954A/en
Publication of WO1996031194A2 publication Critical patent/WO1996031194A2/en
Publication of WO1996031194A9 publication Critical patent/WO1996031194A9/en
Publication of WO1996031194A3 publication Critical patent/WO1996031194A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

This invention relates to a skin care composition containing a retinoid compound as an active ingredient, which is encapsulated in non-phospholipid liposomes and is chemically stable over a long period of time.
PCT/US1996/004557 1995-04-03 1996-04-03 Skin care compositions containing retinoids and liposomes WO1996031194A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
EP96912539A EP0818988A2 (en) 1995-04-03 1996-04-03 Skin care compositions containing retinoids and liposomes
EA199700289A EA199700289A1 (en) 1995-04-03 1996-04-03 COMPOSITIONS FOR SKIN CARE CONTAINING RETINOIDS AND LIPOSOMES
JP8530447A JPH11503165A (en) 1995-04-03 1996-04-03 Skin care composition containing retinoids and liposomes
APAP/P/1997/001101A AP789A (en) 1995-04-03 1996-04-03 Skin care compositions containing retinoids and liposomes.
NZ306694A NZ306694A (en) 1995-04-03 1996-04-03 Skin care composition containing a retinoid
AU55322/96A AU5532296A (en) 1995-04-03 1996-04-03 Skin care compositions containing retinoids and liposomes
BR9604954A BR9604954A (en) 1995-04-03 1996-04-03 Skin care compositions containing retinoids and liposomes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41597595A 1995-04-03 1995-04-03
US08/415,975 1995-04-03

Publications (3)

Publication Number Publication Date
WO1996031194A2 WO1996031194A2 (en) 1996-10-10
WO1996031194A9 WO1996031194A9 (en) 1996-11-21
WO1996031194A3 true WO1996031194A3 (en) 1997-01-23

Family

ID=23648011

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/004557 WO1996031194A2 (en) 1995-04-03 1996-04-03 Skin care compositions containing retinoids and liposomes

Country Status (15)

Country Link
EP (1) EP0818988A2 (en)
JP (1) JPH11503165A (en)
KR (1) KR19980703668A (en)
CN (1) CN1185729A (en)
AP (1) AP789A (en)
AU (1) AU5532296A (en)
BR (1) BR9604954A (en)
CA (1) CA2217201A1 (en)
CZ (1) CZ311997A3 (en)
EA (1) EA199700289A1 (en)
HU (1) HUP9801607A3 (en)
NZ (1) NZ306694A (en)
OA (1) OA10520A (en)
PL (1) PL322624A1 (en)
WO (1) WO1996031194A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9771585B2 (en) 2015-06-05 2017-09-26 MiRagen Therapeutics, Inc. miR-155 inhibitors for treating cutaneous T cell lymphoma (CTCL)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183774B1 (en) 1996-01-31 2001-02-06 Collaborative Laboratories, Inc. Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
US6068847A (en) * 1996-10-03 2000-05-30 Johnson & Johnson Consumer Products, Inc. Cosmetic compositions
DE19713368A1 (en) * 1997-03-29 1998-10-01 Beiersdorf Ag Preparations with active ingredients sensitive to oxidation
FR2771635A1 (en) * 1997-12-01 1999-06-04 Capsulis Encapsulation of active materials in multilamellar vesicles containing an agent to prevent degradation
FR2771636B1 (en) * 1997-12-01 2001-06-15 Capsulis IMPROVED METHOD FOR AVOIDING THE DEGRADATION OF AN ACTIVE INGREDIENT
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
DE19839402A1 (en) * 1998-08-29 2000-03-02 Beiersdorf Ag Stable oil-in-water retinoid emulsion useful for skin care contains selected emulsifier(s) based on e.g. glyceryl stearate and polyethylene glycol (PEG) 30 stearate
FR2787730B1 (en) 1998-12-29 2001-02-09 Oreal POLY (ALKYLENE ADIPATE) NANOCAPSULES, PROCESS FOR THEIR PREPARATION AND COSMETIC OR DERMATOLOGICAL COMPOSITIONS CONTAINING THEM
JP3641152B2 (en) * 1999-02-17 2005-04-20 株式会社ヤクルト本社 Topical skin preparation
CA2309373A1 (en) * 1999-05-27 2000-11-27 Johnson & Johnson Consumer Companies, Inc. Novel topical formulations
US20030003170A1 (en) 2000-06-02 2003-01-02 Theresa Callaghan Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
JP2001122735A (en) * 1999-10-28 2001-05-08 Kose Corp Skin lotion
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US6468552B1 (en) 2000-06-02 2002-10-22 Neutrogena Corporation Stabilized compositions containing oxygen-labile active agents
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
KR100389670B1 (en) * 2000-12-21 2003-07-02 주식회사 티씨 싸이언스 A novel retinol derivative as an anti-aging agent and process for preparing thereof
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
ATE455579T1 (en) 2001-02-28 2010-02-15 Johnson & Johnson Consumer COMPOSITIONS CONTAINING SOY PRODUCTS
AU2002305054B2 (en) 2001-03-16 2006-09-07 Johnson & Johnson Consumer Inc. Composition containing feverfew extract and use thereof
DE10117842A1 (en) * 2001-04-04 2002-10-17 Coty Bv Cosmetic vitamin A-containing preparation
US6797697B2 (en) 2001-05-21 2004-09-28 Johnson & Johnson Consumer Companies, Inc. Composition containing a peptide and a pigment and the use thereof in darkening the skin
US7214655B2 (en) 2001-05-21 2007-05-08 Johnson & Johnson Consumer Companies, Inc. Peptides and the use thereof in darkening the skin
US7081442B2 (en) 2001-05-21 2006-07-25 Johnson & Johnson Consumer Companies, Inc. Composition containing a peptide and a pigment and the use thereof in darkening the skin
KR100439068B1 (en) * 2001-09-07 2004-07-05 주식회사 코리아나화장품 Stablized cosmetic material containing triple layered retonol
DE10212865B4 (en) * 2002-03-22 2005-05-04 Beiersdorf Ag Use of 9-retinal alkanolamine Schiff base in cosmetic dermatological formulations
AU2003213345A1 (en) * 2002-03-29 2003-10-13 Kose Corporation Cosmetic preparation
US7025951B2 (en) 2002-06-18 2006-04-11 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for darkening the skin
EP1572176A2 (en) * 2002-12-12 2005-09-14 Galderma Research & Development, S.N.C. Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid
HUE036596T2 (en) * 2004-06-18 2018-07-30 Univ Washington Retinal derivatives and methods for the use thereof for the treatment of visual disorders
US7381707B2 (en) 2005-06-30 2008-06-03 Johnson & Johnson Consumer Companies, Inc. Treatment of dry eye
US20130149362A1 (en) * 2007-03-15 2013-06-13 Benjamin Johnson Treatment product and method
US20120141576A1 (en) * 2007-03-15 2012-06-07 Benjamin Johnson Treatment of Dermatologic Skin Disorders
CA2721210C (en) 2008-04-21 2017-05-16 Mcneil-Ppc, Inc. Dual spray can topical delivery device
US8642655B2 (en) 2011-03-09 2014-02-04 Benjamin Johnson Systems and methods for preventing cancer and treating skin lesions
EP2540303A1 (en) 2011-06-28 2013-01-02 Johnson & Johnson Consumer Companies Inc. Divalent cation containing compositions and methods for treating and/or preventing enzymatic irritation
US20130004580A1 (en) 2011-06-28 2013-01-03 Lin Connie B Divalent cation/talc containing compositions and methods for treating and/or preventing enzymatic irritation
US20130004590A1 (en) 2011-06-28 2013-01-03 Lin Connie B Zinc oxide/acid containing compositions and methods for treating and/or preventing enzymatic irritation
US9375388B2 (en) 2011-09-23 2016-06-28 Indian Institute Of Technology, Bombay Nanoparticle based cosmetic composition
KR102105210B1 (en) 2012-11-26 2020-04-27 코웨이 주식회사 Cosmetic composition of oil in water emulsion stabilized retinoids derivative
MX372738B (en) 2013-12-23 2020-05-06 Dermopartners S L PROCEDURE FOR PREPARING LIPOSOMES OF RETINALDEHYDE OR OTHER PRECURSORS OF RETINOIC ACID AND PRODUCT THUS OBTAINED.
KR102134931B1 (en) 2013-12-27 2020-07-16 코웨이 주식회사 Cosmetic composition comprising transparent and visible spherical particles
CN108542848A (en) * 2018-05-24 2018-09-18 广州銮滢化妆品有限公司 A kind of crease-resistant topical composition and preparation method thereof containing nanometer retinene
US20210186845A1 (en) * 2019-12-18 2021-06-24 Barnet Products, LLC Vitamin a and vitamin c combinations with enhanced stability
KR102203420B1 (en) * 2020-08-10 2021-01-18 한국콜마주식회사 Liposome complex and cosmetic composition for improving skin condition comprising the same
WO2022219018A1 (en) * 2021-04-16 2022-10-20 Dsm Ip Assets B.V. Retinol formulation (iii)
CN116440025A (en) * 2022-01-08 2023-07-18 浙江睿颜新材料科技有限公司 Efficient and high-stability retinoid compound nanoemulsion
CN114939079B (en) * 2022-05-19 2024-04-23 上海奥利实业有限公司 Preparation method and application of retinol and its derivative inclusion

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0423011A1 (en) * 1989-10-12 1991-04-17 L'oreal Cosmetic or pharmaceutic composition for topical application containing at least a retinoide derivative and at least a pyrimidine derivative

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0423011A1 (en) * 1989-10-12 1991-04-17 L'oreal Cosmetic or pharmaceutic composition for topical application containing at least a retinoide derivative and at least a pyrimidine derivative

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9771585B2 (en) 2015-06-05 2017-09-26 MiRagen Therapeutics, Inc. miR-155 inhibitors for treating cutaneous T cell lymphoma (CTCL)
US9994852B2 (en) 2015-06-05 2018-06-12 MiRagen Therapeutics, Inc. Oligonucleotide compositions and uses thereof
US10316318B2 (en) 2015-06-05 2019-06-11 MiRagen Therapeutics, Inc. Oligonucleotide compositions and uses thereof

Also Published As

Publication number Publication date
CN1185729A (en) 1998-06-24
CA2217201A1 (en) 1996-10-10
EP0818988A2 (en) 1998-01-21
WO1996031194A2 (en) 1996-10-10
AU5532296A (en) 1996-10-23
HUP9801607A3 (en) 1999-03-01
KR19980703668A (en) 1998-12-05
EA199700289A1 (en) 1998-04-30
AP9701101A0 (en) 1997-10-31
NZ306694A (en) 2000-01-28
CZ311997A3 (en) 1998-01-14
BR9604954A (en) 1998-06-09
AP789A (en) 1999-12-03
JPH11503165A (en) 1999-03-23
OA10520A (en) 2002-04-22
PL322624A1 (en) 1998-02-02
HUP9801607A2 (en) 1999-01-28

Similar Documents

Publication Publication Date Title
WO1996031194A3 (en) Skin care compositions containing retinoids and liposomes
HUP9901228A3 (en) Cyclic amides, their intermediates, arthropodicide and fungicide compositions containing theses compounds as active ingredients and use thereof
EP0806201A3 (en) Foamable cosmetic mask product
CA2213411A1 (en) Reduction of hair growth
AU3459789A (en) Aqueous compositions of pyroglutamic acid esters for topical application to human skin and hair
ID21858A (en) COMPOSITIONS OF SKIN CARE CONTAINING AMIDA AND RETINOID
CA2237979A1 (en) Reduction of hair growth
ID21761A (en) COMPOSITION OF SKIN CARE CONTAINING ACID AND RETINOID
AU1901897A (en) Skin care compositions containing fatty acid amides, azoles and retinol or retinyl ester
MY130044A (en) Retinoid composition
AU4864396A (en) Anhydrous cosmetic compositions with dermatologically active agents
BG103404A (en) Compositions containing antimycotic formulation and phospholipid
RU2001120373A (en) Skin Lightening Composition
AU5853996A (en) Cosmetic deodorant compositions containing encapsulated bica rbonate
CA2303370A1 (en) Dentifrices of enhanced efficacy containing fluoride and casein glycomacropeptide
TR199802573A2 (en) Precipitated silicas containing an active ingredient.
HUP9900795A3 (en) Sinergetical fungicide composition containing fenazaquine and amide compound as active ingredients and use thereof
ID16817A (en) COMPOSITIONS OF SKIN CARE CONTAINING MELINAMIDE AND A RETINOID
WO2002053124A3 (en) Stable skin care compositions containing a retinoid and a retinoid booster system
WO2002036090A3 (en) Cosmetic plaster for bleaching the skin
AU4789296A (en) Cosmetic cleansing compositions comprising esters of alkylglycosides
HK218796A (en) Anti-calculus oral hygiene compositions
HUP9801651A3 (en) Hydroximic acid derivatives, intermediates, preparation and use thereof, pesticide compositions containing these compounds as active ingredients
EP0396232A3 (en) Oral rinse compositions
KR880007068A (en) Use of 13-cis retinoic acid

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 96194264.9

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML

COP Corrected version of pamphlet

Free format text: PAGE 18,DESCRIPTION,AND PAGES 1/4-4/4,DRAWINGS,REPLACED BY NEW PAGES BEARING THE SAME NUMBER;DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 306694

Country of ref document: NZ

ENP Entry into the national phase

Ref document number: 2217201

Country of ref document: CA

Ref document number: 2217201

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PV1997-3119

Country of ref document: CZ

Ref document number: 1019970707067

Country of ref document: KR

ENP Entry into the national phase

Ref document number: 1996 530447

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1996912539

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 199700289

Country of ref document: EA

WWP Wipo information: published in national office

Ref document number: PV1997-3119

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1996912539

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1019970707067

Country of ref document: KR

WWR Wipo information: refused in national office

Ref document number: PV1997-3119

Country of ref document: CZ

WWR Wipo information: refused in national office

Ref document number: 1996912539

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1996912539

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1019970707067

Country of ref document: KR